Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma
NCT04840875
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
T Cell Lymphoma
T-cell Leukemia
Interventions
BIOLOGICAL:
chimeric antigen receptor T cell treatment
Sponsor
Beijing Boren Hospital